ArticleMolecular biotechnology2026
WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Obesity.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- T-Cell Signaling Pathways, Including Exhaustion, Predominate in Unhealthy Visceral and Subcutaneous Adipose Tissues.Obesity (Silver Spring, Md.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The prevalence of obesity is increasing year by year, but its characteristic molecular targets are still unclear, and the available therapeutic approaches are relatively limited. Therefore, it is crucial to elucidate the molecular mechanisms underlying the pathogenesis of obesity and to explore potential molecular targets for obesity drug therapy. The expression dataset (GSE73304) was downloaded from the gene expression omnibus database for between-group differential expression gene analyses (DEGs), genome enrichment analysis (GSEA), and weighted gene co-expression network analysis (WGCNA) in healthy and obese populations. Intersecting genes obtained from DEGs and WGCNA difference modules were analyzed with three machine learning methods (LASSO, RandomForest, SVM-REF) to obtain obesity characteristic Genes. Analysis of ROC curves, intergroup differences, and intergene correlations for Genes characterizing obesity. The results of the study showed that 10 specimens and their Gene expression matrices were collected from each of the normal and obese patient groups, yielding 1937 DEGs. GSEA results showed that DEGs were enriched for 32 significant KEGG pathways. Forty gene co-expression modules of the gene expression matrix were constructed by WGCNA. Forty-five intersecting genes were obtained from DEGs and WGCNA significant difference module, which were associated with cellular differentiation, mitochondria, and a variety of endocrine factors and hormones. Eleven genes, including XLOC_004699, RIMBP2, COX6B2, OR5T1, RXFP2, XLOC_003676, XLOC_013038, VAX1, Q07610, XLOC_011515, and PTPN3, were obtained as the obesity characterization Genes through machine learning analysis of intersecting Genes. Based on WGCNA and machine learning, this study found that 11 genes, including RIMBP2, COX6B2, and OR5T1, differed significantly between healthy and obese populations and were closely associated with multiple molecular mechanisms, and these genes may be potential targets for drug therapy and diagnostic biomarkers.
Indexed as
Identifiers
40956396What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.